1219P Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study

1219P Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S1106
Main Authors: Chalabi, M., Verschoor, Y.L., Van De Haar, J., van den Berg, J., Kodach, L., van Sandick, J., van Dieren, J., Balduzzi, S., Grootscholten, M.C., Veenhof, X., Hartemink, K., Vollebergh, M., Owers, E., Bartels-Rutten, A., den Hartog-Lievaart, P., van Leerdam, M., Schumacher, T.N., Haanen, J.B.A.G., Voest, E.E.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1337